Muscle selection patterns for injection of onabotulinumtoxinA in adult patients with post-stroke lower-limb spasticity influence outcome: Results from a double-blind, placebo-controlled phase 3 clinical trial

被引：0
|
作者：
Wein, T. H.
Esquenazi, A.
Ward, A. B.
Geis, C.
Liu, C.
Dimitrova, R.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
959
引用
收藏
页码：S306 / S306
页数：1
相关论文
共 50 条
  • [41] Safety results from a double-blind, placebo-controlled clinical trial in patients receiving high-dose terbinafine
    Tavakkol, A
    Glenn, K
    Warsi, G
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P128 - P128
  • [42] Dupilumab treatment in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Simpson, E.
    Silverberg, J.
    Worm, M.
    Honari, G.
    Masuda, K.
    Sygula, E.
    Maloney, J.
    Mannent, L.
    Xiao, J.
    Dubost-Brama, A.
    Bansal, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S350 - S350
  • [43] Rationale and design of a randomised, double-blind, placebo-controlled study to assess the impact of early use of abobotulinum toxin A on spasticity progression in adults with post-stroke upper limb spasticity in Asia (ONTIME study)
    Rosales, R. L.
    Balcaitiene, J.
    Maisonobe, P.
    Kong, K. H.
    Goh, K. J.
    Kumthornthip, W.
    MOVEMENT DISORDERS, 2015, 30 : S554 - S555
  • [44] Natalizumab versus placebo in patients with secondary progressive multiple sclerosis (SPMS): Results from ASCEND, a multicenter, double-blind, placebo-controlled, randomized phase 3 clinical trial
    Steiner, Deborah
    Arnold, Douglas
    Freedman, Mark
    Goldman, Myla
    Hartung, Hans-Peter
    Havrdova, Eva
    Jeffery, Douglas
    Kapoor, Raj
    Miller, Aaron
    Sellebjerg, Finn
    Amarante, Diogo
    Cadavid, Diego
    Yu, Bei
    Forrestal, Fiona
    Liu, Kezhen
    NEUROLOGY, 2016, 87 (02) : E22 - E22
  • [45] GOAL ATTAINMENT SCALING IN THE EVALUATION OF TREATMENT OF UPPER LIMB SPASTICITY WITH BOTULINUM TOXIN: A SECONDARY ANALYSIS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL
    Turner-Stokes, Lynne
    Baguley, Ian J.
    De Graaff, Stephen
    Katrak, Pesi
    Davies, Leo
    McCrory, Paul
    Hughes, Andrew
    JOURNAL OF REHABILITATION MEDICINE, 2010, 42 (01) : 81 - 89
  • [46] Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
    Nakaoka, Yoshikazu
    Isobe, Mitsuaki
    Takei, Syuji
    Tanaka, Yoshiya
    Ishii, Tomonori
    Yokota, Shumpei
    Nomura, Akira
    Yoshida, Seitaro
    Nishimoto, Norihiro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [47] Rapid decrease in migraine days with rimegepant: Results from a post hoc analysis of a phase 2/3, randomized, double-blind, placebo-controlled trial
    Lipton, R. B.
    Croop, R.
    Jensen, C. M.
    Thiry, A. C.
    Kim, E.
    Kamen, L.
    Coric, V
    Goadsby, P. J.
    HEADACHE, 2021, 61 : 138 - 139
  • [48] Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries
    Buvat, Jacques
    Tesfaye, Fisseha
    Rothman, Margaret
    Rivas, David A.
    Giuliano, Francois
    EUROPEAN UROLOGY, 2009, 55 (04) : 957 - 968
  • [49] Impact of Scleroderma-Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial of Tocilizumab in Scleroderma
    Al Dulaijan, Basmah
    Huang, Suiyuan
    Lin, Celia J. F.
    Denton, Christopher P.
    Khanna, Dinesh
    ACR OPEN RHEUMATOLOGY, 2025, 7 (01)
  • [50] OnabotulinumtoxinA Treatment Reduces Headache Duration in Adults with Chronic Migraine: Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT Clinical Program
    Dodick, D. W.
    Diener, H. -C.
    DeGryse, R. E.
    Turkel, C. C.
    HEADACHE, 2010, 50 : S58 - S59
12345